2025-01-16
RI039, RNase Inhibitor, Human Placenta,I.e. Ribonuclease Prohibitor, Human Placenta is a recombinant expression of human placental RNase inhibitor in Escherichia coli, which can bind to RNase A, RNase B, RNase C, and human placental RNase in a non competitive 1:1 ratio and inhibit their activity, thereby protecting RNA from degradation by these enzymes.
2022-01-13
RSTI19, Recombinant Soybean (trypsin Inhibitor), Animal free. NLT 1.0 U/mg pro.
2022-01-13
RTI16, Recombinant Aprotinin (trypsin inhibitor, BPTI), Animal free. NLT3.0 EPU/mg pro.
2021-12-22
RNK3501, GMP-RI01, recombinant Murine Ribonuclease Inhibitor, 40U/μl, GMP Grade, for medical mRNA synthesis and other biopharmaceutical production, 40U/μl*75μl/vial